Co-Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CODX Nasdaq 3840 co-dx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Co-Diagnostics, Inc.

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform - Jul 22nd, 2026 7:00 am
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin - Jul 22nd, 2026 6:46 am
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - Jul 16th, 2026 7:00 am
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand - Jul 8th, 2026 7:00 am
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test - Jul 1st, 2026 7:00 am
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform - Jul 1st, 2026 6:45 am
Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States - Jun 25th, 2026 7:00 am
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line - Jun 18th, 2026 7:00 am
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement - Jun 11th, 2026 7:00 am
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities - Jun 2nd, 2026 7:00 am
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - May 28th, 2026 9:00 am
Co-Diagnostics (CODX) Q4 2025 Earnings Transcript - May 27th, 2026 2:52 pm
Top Midday Gainers - May 26th, 2026 11:54 am
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - May 26th, 2026 11:00 am
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara - May 26th, 2026 7:00 am
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - May 19th, 2026 8:54 pm
Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX) - May 19th, 2026 8:34 am
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert - May 19th, 2026 7:00 am
Co-Diagnostics (CODX) Q1 2026 Earnings Transcript - May 15th, 2026 11:31 am
Co-Diagnostics, Inc. Q1 2026 Earnings Call Summary - May 15th, 2026 6:30 am